4.3 Letter

Impact of salvage treatment phase on inotuzumab ozogamicin treatment for relapsed/refractory acute lymphoblastic leukemia: an update from the INO-VATE final study database

Journal

LEUKEMIA & LYMPHOMA
Volume 61, Issue 8, Pages 2012-2015

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/10428194.2020.1751839

Keywords

-

Funding

  1. Pfizer

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available